LifeStance Health Group (LFST) Competitors

$7.65 -0.24 (-3.04%)

Closing price 04:00 PM Eastern

Extended Trading

$7.62 -0.03 (-0.33%)

As of 05:46 PM Eastern

LFST vs. FMS, BTSG, CELC, HIMS, and CAI

Should you buy LifeStance Health Group stock or one of its competitors? MarketBeat compares LifeStance Health Group with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with LifeStance Health Group include Fresenius Medical Care AG & Co. KGaA (FMS), BrightSpring Health Services (BTSG), Celcuity (CELC), Hims & Hers Health (HIMS), and Caris Life Sciences (CAI). These companies are all part of the "healthcare" industry.

How does LifeStance Health Group compare to Fresenius Medical Care AG & Co. KGaA?

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) and LifeStance Health Group (NASDAQ:LFST) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, valuation, analyst recommendations, media sentiment, institutional ownership, earnings, dividends and profitability.

Fresenius Medical Care AG & Co. KGaA currently has a consensus price target of $28.00, indicating a potential upside of 29.54%. LifeStance Health Group has a consensus price target of $9.86, indicating a potential upside of 28.85%. Given Fresenius Medical Care AG & Co. KGaA's higher possible upside, equities analysts plainly believe Fresenius Medical Care AG & Co. KGaA is more favorable than LifeStance Health Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Fresenius Medical Care AG & Co. KGaA	4 Sell rating(s)	5 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.56
LifeStance Health Group	0 Sell rating(s)	2 Hold rating(s)	6 Buy rating(s)	2 Strong Buy rating(s)	3.00

Fresenius Medical Care AG & Co. KGaA has a beta of 0.81, indicating that its stock price is 19% less volatile than the broader market. Comparatively, LifeStance Health Group has a beta of 1.2, indicating that its stock price is 20% more volatile than the broader market.

8.4% of Fresenius Medical Care AG & Co. KGaA shares are held by institutional investors. Comparatively, 85.5% of LifeStance Health Group shares are held by institutional investors. 3.2% of LifeStance Health Group shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Fresenius Medical Care AG & Co. KGaA has higher revenue and earnings than LifeStance Health Group. Fresenius Medical Care AG & Co. KGaA is trading at a lower price-to-earnings ratio than LifeStance Health Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Fresenius Medical Care AG & Co. KGaA	$22.20B	0.54	$1.11B	$1.90	11.38
LifeStance Health Group	$1.42B	2.08	$9.66M	$0.06	127.50

Fresenius Medical Care AG & Co. KGaA has a net margin of 4.88% compared to LifeStance Health Group's net margin of 1.55%. Fresenius Medical Care AG & Co. KGaA's return on equity of 8.90% beat LifeStance Health Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Fresenius Medical Care AG & Co. KGaA	4.88%	8.90%	4.05%
LifeStance Health Group	1.55%	1.56%	1.07%

In the previous week, LifeStance Health Group had 16 more articles in the media than Fresenius Medical Care AG & Co. KGaA. MarketBeat recorded 19 mentions for LifeStance Health Group and 3 mentions for Fresenius Medical Care AG & Co. KGaA. Fresenius Medical Care AG & Co. KGaA's average media sentiment score of 1.23 beat LifeStance Health Group's score of 0.43 indicating that Fresenius Medical Care AG & Co. KGaA is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Fresenius Medical Care AG & Co. KGaA	2 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
LifeStance Health Group	5 Very Positive mention(s)	4 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

LifeStance Health Group beats Fresenius Medical Care AG & Co. KGaA on 9 of the 17 factors compared between the two stocks.

How does LifeStance Health Group compare to BrightSpring Health Services?

BrightSpring Health Services (NASDAQ:BTSG) and LifeStance Health Group (NASDAQ:LFST) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their analyst recommendations, media sentiment, institutional ownership, valuation, earnings, risk, profitability and dividends.

BrightSpring Health Services has a beta of 1.71, indicating that its share price is 71% more volatile than the broader market. Comparatively, LifeStance Health Group has a beta of 1.2, indicating that its share price is 20% more volatile than the broader market.

BrightSpring Health Services currently has a consensus price target of $56.29, indicating a potential downside of 2.79%. LifeStance Health Group has a consensus price target of $9.86, indicating a potential upside of 28.85%. Given LifeStance Health Group's higher probable upside, analysts plainly believe LifeStance Health Group is more favorable than BrightSpring Health Services.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
BrightSpring Health Services	0 Sell rating(s)	0 Hold rating(s)	15 Buy rating(s)	2 Strong Buy rating(s)	3.12
LifeStance Health Group	0 Sell rating(s)	2 Hold rating(s)	6 Buy rating(s)	2 Strong Buy rating(s)	3.00

BrightSpring Health Services has higher revenue and earnings than LifeStance Health Group. BrightSpring Health Services is trading at a lower price-to-earnings ratio than LifeStance Health Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
BrightSpring Health Services	$13.65B	0.82	$190.67M	$1.41	41.06
LifeStance Health Group	$1.42B	2.08	$9.66M	$0.06	127.50

85.5% of LifeStance Health Group shares are owned by institutional investors. 2.8% of BrightSpring Health Services shares are owned by insiders. Comparatively, 3.2% of LifeStance Health Group shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

In the previous week, LifeStance Health Group had 12 more articles in the media than BrightSpring Health Services. MarketBeat recorded 19 mentions for LifeStance Health Group and 7 mentions for BrightSpring Health Services. BrightSpring Health Services' average media sentiment score of 0.67 beat LifeStance Health Group's score of 0.43 indicating that BrightSpring Health Services is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
BrightSpring Health Services	2 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
LifeStance Health Group	5 Very Positive mention(s)	4 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

BrightSpring Health Services has a net margin of 2.27% compared to LifeStance Health Group's net margin of 1.55%. BrightSpring Health Services' return on equity of 14.63% beat LifeStance Health Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
BrightSpring Health Services	2.27%	14.63%	4.41%
LifeStance Health Group	1.55%	1.56%	1.07%

Summary

BrightSpring Health Services beats LifeStance Health Group on 10 of the 16 factors compared between the two stocks.

How does LifeStance Health Group compare to Celcuity?

Celcuity (NASDAQ:CELC) and LifeStance Health Group (NASDAQ:LFST) are both mid-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their analyst recommendations, media sentiment, institutional ownership, valuation, earnings, risk, profitability and dividends.

LifeStance Health Group has higher revenue and earnings than Celcuity. Celcuity is trading at a lower price-to-earnings ratio than LifeStance Health Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Celcuity	N/A	N/A	-$177.04M	-$3.79	N/A
LifeStance Health Group	$1.42B	2.08	$9.66M	$0.06	127.50

Celcuity currently has a consensus price target of $140.20, indicating a potential upside of 1.83%. LifeStance Health Group has a consensus price target of $9.86, indicating a potential upside of 28.85%. Given LifeStance Health Group's stronger consensus rating and higher probable upside, analysts plainly believe LifeStance Health Group is more favorable than Celcuity.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Celcuity	1 Sell rating(s)	1 Hold rating(s)	10 Buy rating(s)	0 Strong Buy rating(s)	2.75
LifeStance Health Group	0 Sell rating(s)	2 Hold rating(s)	6 Buy rating(s)	2 Strong Buy rating(s)	3.00

Celcuity has a beta of 0.09, indicating that its share price is 91% less volatile than the broader market. Comparatively, LifeStance Health Group has a beta of 1.2, indicating that its share price is 20% more volatile than the broader market.

In the previous week, LifeStance Health Group had 7 more articles in the media than Celcuity. MarketBeat recorded 19 mentions for LifeStance Health Group and 12 mentions for Celcuity. Celcuity's average media sentiment score of 0.65 beat LifeStance Health Group's score of 0.43 indicating that Celcuity is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Celcuity	3 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	2 Very Negative mention(s)	Positive
LifeStance Health Group	5 Very Positive mention(s)	4 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

LifeStance Health Group has a net margin of 1.55% compared to Celcuity's net margin of 0.00%. LifeStance Health Group's return on equity of 1.56% beat Celcuity's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Celcuity	N/A	-203.17%	-52.68%
LifeStance Health Group	1.55%	1.56%	1.07%

63.3% of Celcuity shares are owned by institutional investors. Comparatively, 85.5% of LifeStance Health Group shares are owned by institutional investors. 13.3% of Celcuity shares are owned by insiders. Comparatively, 3.2% of LifeStance Health Group shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Summary

LifeStance Health Group beats Celcuity on 13 of the 16 factors compared between the two stocks.

How does LifeStance Health Group compare to Hims & Hers Health?

LifeStance Health Group (NASDAQ:LFST) and Hims & Hers Health (NYSE:HIMS) are both mid-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, analyst recommendations, institutional ownership, earnings, media sentiment, risk, dividends and valuation.

Hims & Hers Health has higher revenue and earnings than LifeStance Health Group. Hims & Hers Health is trading at a lower price-to-earnings ratio than LifeStance Health Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
LifeStance Health Group	$1.42B	2.08	$9.66M	$0.06	127.50
Hims & Hers Health	$2.37B	2.41	$128.37M	-$0.09	N/A

LifeStance Health Group has a beta of 1.2, indicating that its stock price is 20% more volatile than the broader market. Comparatively, Hims & Hers Health has a beta of 2.43, indicating that its stock price is 143% more volatile than the broader market.

85.5% of LifeStance Health Group shares are held by institutional investors. Comparatively, 63.5% of Hims & Hers Health shares are held by institutional investors. 3.2% of LifeStance Health Group shares are held by company insiders. Comparatively, 11.8% of Hims & Hers Health shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

LifeStance Health Group presently has a consensus price target of $9.86, suggesting a potential upside of 28.85%. Hims & Hers Health has a consensus price target of $29.50, suggesting a potential upside of 17.70%. Given LifeStance Health Group's stronger consensus rating and higher possible upside, equities research analysts plainly believe LifeStance Health Group is more favorable than Hims & Hers Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
LifeStance Health Group	0 Sell rating(s)	2 Hold rating(s)	6 Buy rating(s)	2 Strong Buy rating(s)	3.00
Hims & Hers Health	2 Sell rating(s)	11 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.12

In the previous week, Hims & Hers Health had 56 more articles in the media than LifeStance Health Group. MarketBeat recorded 75 mentions for Hims & Hers Health and 19 mentions for LifeStance Health Group. LifeStance Health Group's average media sentiment score of 0.43 beat Hims & Hers Health's score of -0.01 indicating that LifeStance Health Group is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
LifeStance Health Group	5 Very Positive mention(s)	4 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Hims & Hers Health	16 Very Positive mention(s)	10 Positive mention(s)	11 Neutral mention(s)	24 Negative mention(s)	6 Very Negative mention(s)	Neutral

LifeStance Health Group has a net margin of 1.55% compared to Hims & Hers Health's net margin of -0.56%. Hims & Hers Health's return on equity of 6.10% beat LifeStance Health Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
LifeStance Health Group	1.55%	1.56%	1.07%
Hims & Hers Health	-0.56%	6.10%	1.52%

Summary

LifeStance Health Group beats Hims & Hers Health on 9 of the 17 factors compared between the two stocks.

How does LifeStance Health Group compare to Caris Life Sciences?

LifeStance Health Group (NASDAQ:LFST) and Caris Life Sciences (NASDAQ:CAI) are both mid-cap healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, analyst recommendations, institutional ownership, earnings, media sentiment, risk, dividends and valuation.

LifeStance Health Group has higher revenue and earnings than Caris Life Sciences. Caris Life Sciences is trading at a lower price-to-earnings ratio than LifeStance Health Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
LifeStance Health Group	$1.42B	2.08	$9.66M	$0.06	127.50
Caris Life Sciences	$812.03M	5.07	-$68.09M	-$7.61	N/A

85.5% of LifeStance Health Group shares are held by institutional investors. 3.2% of LifeStance Health Group shares are held by company insiders. Comparatively, 7.8% of Caris Life Sciences shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

LifeStance Health Group presently has a consensus price target of $9.86, suggesting a potential upside of 28.85%. Caris Life Sciences has a consensus price target of $27.56, suggesting a potential upside of 89.39%. Given Caris Life Sciences' higher possible upside, analysts plainly believe Caris Life Sciences is more favorable than LifeStance Health Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
LifeStance Health Group	0 Sell rating(s)	2 Hold rating(s)	6 Buy rating(s)	2 Strong Buy rating(s)	3.00
Caris Life Sciences	1 Sell rating(s)	3 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.50

In the previous week, LifeStance Health Group had 6 more articles in the media than Caris Life Sciences. MarketBeat recorded 19 mentions for LifeStance Health Group and 13 mentions for Caris Life Sciences. LifeStance Health Group's average media sentiment score of 0.43 beat Caris Life Sciences' score of 0.09 indicating that LifeStance Health Group is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
LifeStance Health Group	5 Very Positive mention(s)	4 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Caris Life Sciences	2 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	4 Negative mention(s)	1 Very Negative mention(s)	Neutral

Caris Life Sciences has a net margin of 3.75% compared to LifeStance Health Group's net margin of 1.55%. Caris Life Sciences' return on equity of 98.28% beat LifeStance Health Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
LifeStance Health Group	1.55%	1.56%	1.07%
Caris Life Sciences	3.75%	98.28%	48.87%

Summary

LifeStance Health Group beats Caris Life Sciences on 9 of the 15 factors compared between the two stocks.

Get LifeStance Health Group News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding LFST and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

LFST vs. The Competition

Export

Metric	LifeStance Health Group	MED Industry	Medical Sector	NASDAQ Exchange
Market Cap	$2.97B	$5.51B	$6.23B	$12.27B
Dividend Yield	N/A	1.56%	2.80%	5.35%
P/E Ratio	127.50	33.92	20.14	25.23
Price / Sales	2.08	21.68	542.44	73.19
Price / Cash	48.15	16.43	43.26	56.33
Price / Book	2.01	3.14	9.81	6.90
Net Income	$9.66M	$218.81M	$3.56B	$333.88M
7 Day Performance	-0.84%	-1.05%	0.33%	0.04%
1 Month Performance	16.79%	2.68%	-0.98%	1.74%
1 Year Performance	32.12%	15.02%	36.19%	32.64%

LifeStance Health Group Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
LFST LifeStance Health Group	4.2622 of 5 stars	$7.65 -3.0%	$9.86 +28.9%	+37.5%	$2.97B	$1.42B	127.50	10,961	Analyst Forecast Insider Trade
FMS Fresenius Medical Care AG & Co. KGaA	4.8679 of 5 stars	$20.16 -11.0%	$28.00 +38.9%	-22.8%	$11.26B	$19.63B	10.55	1,488	High Trading Volume
BTSG BrightSpring Health Services	3.2887 of 5 stars	$51.44 -3.9%	$55.29 +7.5%	+148.6%	$9.94B	$12.91B	36.48	23,500
CELC Celcuity	1.7527 of 5 stars	$141.69 -2.3%	$134.50 -5.1%	+1,140.5%	$6.85B	N/A	N/A	40	News Coverage Earnings Report Analyst Forecast Gap Down
HIMS Hims & Hers Health	3.8159 of 5 stars	$26.35 -3.4%	$32.33 +22.7%	-60.8%	$6.01B	$2.35B	51.68	2,442	Trending News Earnings Report Analyst Forecast Options Volume

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:LFST) was last updated on 5/15/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

LifeStance Health Group (LFST) Competitors

LFST vs. FMS, BTSG, CELC, HIMS, and CAI

How does LifeStance Health Group compare to Fresenius Medical Care AG & Co. KGaA?

Summary

How does LifeStance Health Group compare to BrightSpring Health Services?

Summary

How does LifeStance Health Group compare to Celcuity?

Summary

How does LifeStance Health Group compare to Hims & Hers Health?

Summary

How does LifeStance Health Group compare to Caris Life Sciences?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

LFST vs. The Competition

LifeStance Health Group Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

LifeStance Health Group (LFST) Competitors

LFST vs. FMS, BTSG, CELC, HIMS, and CAI

How does LifeStance Health Group compare to Fresenius Medical Care AG & Co. KGaA?

Do analysts recommend FMS or LFST?

Which has more risk and volatility, FMS or LFST?

Do insiders and institutionals believe in FMS or LFST?

Which has higher valuation & earnings, FMS or LFST?

Is FMS or LFST more profitable?

Does the media prefer FMS or LFST?

Summary

How does LifeStance Health Group compare to BrightSpring Health Services?

Which has more volatility & risk, BTSG or LFST?

Do analysts recommend BTSG or LFST?

Which has stronger valuation and earnings, BTSG or LFST?

Do institutionals and insiders believe in BTSG or LFST?

Does the media prefer BTSG or LFST?

Is BTSG or LFST more profitable?

Summary

How does LifeStance Health Group compare to Celcuity?

Which has stronger valuation and earnings, CELC or LFST?

Do analysts recommend CELC or LFST?

Which has more volatility & risk, CELC or LFST?

Does the media prefer CELC or LFST?

Is CELC or LFST more profitable?

Do institutionals and insiders believe in CELC or LFST?

Summary

How does LifeStance Health Group compare to Hims & Hers Health?

Which has better earnings and valuation, LFST or HIMS?

Which has more risk & volatility, LFST or HIMS?

Do institutionals & insiders have more ownership in LFST or HIMS?

Do analysts rate LFST or HIMS?

Does the media refer more to LFST or HIMS?

Is LFST or HIMS more profitable?

Summary

How does LifeStance Health Group compare to Caris Life Sciences?

Which has better earnings and valuation, LFST or CAI?

Do institutionals & insiders have more ownership in LFST or CAI?

Do analysts rate LFST or CAI?

Does the media favor LFST or CAI?

Is LFST or CAI more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

LFST vs. The Competition

LifeStance Health Group Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools